Companies

Nautilus Biotechnology, Inc. (NAUT) SEC filings

CIK 0001808805 · Laboratory Analytical Instruments (SIC 3826) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-59.0 M-63.7 M-57.9 M
Diluted EPS (USD/shares)-0.47-0.51-0.46

Latest filings

FiledFormDescriptionPeriod
2026-09-18EFFECTEFFECT items ,,
2026-09-18424B5424B5
2026-09-11SCHEDULE 13D/ASCHEDULE 13D/A
2026-09-118-K8-K items 1.01,1.02,9.012026-09-11
2026-09-11S-3S-3
2026-08-28SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-14SCHEDULE 13D/ASCHEDULE 13D/A
2026-07-2810-Q10-Q2026-06-30
2026-07-288-K8-K items 2.02,9.012026-07-28
2026-06-30SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-224FORM 42026-06-18
2026-06-224FORM 42026-06-18
2026-06-224FORM 42026-06-18
2026-06-224FORM 42026-06-18
2026-06-224FORM 42026-06-18
2026-06-188-K8-K items 5.072026-06-17
2026-06-04SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-04442026-06-02
2026-04-28ARSARS2025-12-31
2026-04-28DEFA14ADEFA14A
2026-04-28DEF 14ADEF 14A2026-06-17
2026-04-2810-Q10-Q2026-03-31
2026-04-288-K8-K items 2.02,9.012026-04-28
2026-03-04SCHEDULE 13D/ASCHEDULE 13D/A
2026-03-04SCHEDULE 13D/ASCHEDULE 13D/A

Forms on file (last 1,000): 4 115, 8-K 41, 3 25, 10-Q 19, 144 11, SCHEDULE 13D/A 11, 424B3 11, CORRESP 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NAUT (0.002 USD), /gw/filings/filings?ticker=NAUT&form=8-K, /gw/filings/facts?ticker=NAUT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange